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+
CD8
+ T cells have been demonstrated to play an important role in the control of chronic viral replication; however, the relationship between CXCR5 
+ T cells were reduced by PD-1 pathway blockade, but the production of IFN-γ and TNF-α from CXCR5 -CD8 + T cells increased in response to TCR stimulation. Interestingly, PD-1 expression was constantly retained on CXCR5 +
+ T cells while significantly decreased on CXCR5 -CD8 + T cells after successful antiretroviral treatment in chronic HIV-infected patients. 
CXCR5
+ CD8 + T cells may represent a novel therapeutic strategy for the disease. + T cells and HIV control (1, 2) . Emerging data suggest that if HIV-specific CD8 + T cells can be effectively harnessed, HIV could be eliminated (3) (4) (5) . Although HIV-specific CD8 + T cells showed an exhausted phenotype to a certain extent during chronic HIV infection, they can still inhibit viral replication. Some studies have shown that a subset of CD8 + T cells expressing the chemokine receptor CXCR5 share some features of HIVspecific CD8
+ T cells and play a pivotal role in the control of viral replication during chronic viral infections (6) (7) (8) . In addition, it was reported that CXCR5 + CD8 + T cells exhibit a more potent proinflammatory function than CXCR5 − CD8 + T cells during chronic HIV infections (6, 9) . Despite these findings, the role of CXCR5 + CD8 + T cells in the context of a chronic HIV infection, as well as the effect of ART on CXCR5 + CD8 + T cells require further clarification.
One of the important characteristics of a chronic HIV infection is CD8
+ T cell dysfunction associated with the expression of the programmed cell death 1 (PD-1) inhibitory receptor (10) (11) (12) (13) . PD-1 is a central regulator of CD8 + T cell exhaustion, and blockade of the PD-1 pathway has a beneficial effect on enhancing T cell immunity in chronic viral infections (10) (11) (12) (14) (15) (16) (17) . It has also been reported that a blockade of the PD-1 pathway did not completely restore T cell function (18) (19) (20) 
MaTerials anD MeThODs subjects
All samples were collected with the approval of the Beijing 302 Hospital Research Ethnics Committee and were written informed consent in accordance with the Declaration of Helsinki. The methods were carried out in accordance with approved guidelines and regulations. Peripheral blood for isolation of peripheral blood mononuclear cells (PBMCs) were obtained from HIVinfected patients. Lymph node (LN) biopsies were collected from nine treatment naïve patients. HIV status was defined according to previous reports (26, 27) . Patients included a cohort of 62 TPs (who exhibited a typical progressive disease without receiving antiviral treatment), 26 CRs to antiviral therapy for more than 2 years with peripheral CD4 + T cell counts above 350 cells/μL and plasma HIV-1 RNA <80 copies/mL, and 13 INRs to antiviral therapy for more than 2 years with CD4 + T cell counts below 200 cells/μL and plasma HIV-1 RNA <80 copies/mL. Exclusion criteria included coinfection with HBV, HCV, tuberculosis, pregnancy, and moribund status (28) . The detailed information for the donors is listed in Table 1 .
Plasma hiV-1 rna Monitoring
The HIV-1 RT-PCR Assay V2 (QIAGEN, Hilden, Germany) and CFX96 Real-Time System (Bio Rad Laboratories, Hercules, CA, USA) were used to quantify the HIV-1 RNA levels in plasma as previously described (11, 29) . The cut-off value was 80 copies/mL.
Flow cytometry
For phenotypic staining, PBMCs and milled LN cells were extracellularly stained using antibodies specific to respective markers, including anti-CD3-PerCP (BD Biosciences, Franklin Lakes, NJ, USA), anti-CD8-FITC (eBioscience, Waltham, MA, USA), anti-CXCR5-eFlour450 (eBioscience, Waltham, MA, USA), anti-PD-1-BV500 (BD Biosciences, Franklin Lakes, NJ, USA), and HIV Pentamer-PE (HIV-1 gag p17 76-84R, HIV-1 gag gp41 67-75R, and HIV-1 nef 72-82R) (Proimmune, Oxford, UK) for 30 min at room temperature. The cells were washed with FACS buffer, and assessed by flow cytometry (6) . After extracellular staining, the cells were permeabilized, fixed and stained using the Permeabilization/Fixation Kit according to manufacturer's instructions (eBioscience, Waltham, MA, USA). The cells were then incubated for 30 min at 4°C with antibodies specific to granzyme B-FITC (BD Biosciences, Franklin Lakes, NJ, USA) and perforin-Alexa647 (BD Biosciences, Franklin Lakes, NJ, USA).
After stimulated by overlapping peptides covering the HIV-1 pol, gag, and env antigens (JPT, Berlin, Germany) for 8 hrs with or without PD-L1(10 µg/mL) in the presence of brefeldin A and CD107a-eFluor660 (eBioscience, Waltham, MA, USA), extracellular stained, and permeabilized, the PBMCs or sorted cells were then incubated for 30 min at 4°C with antibodies specific to IFN-γ-eFlour506 (eBioscience, Waltham, MA, USA) and TNF-α-PE-Cy7 (eBioscience, Waltham, MA, USA). Flow cytometric acquisition was performed on a FACSVerse or Caliber.
immunohistochemistry and confocal Microscopy
Paraffin-embedded sections of acetone-fixed LN biopsies were incubated with anti-CD8, anti-CXCR5, and anti-CD20 antibodies overnight at 4°C after the endogenous peroxidase activity was blocked with 0.3% H2O2. 3-amino-9-ethyl-carbazole (red color) was used as the substrate followed by counterstaining with hematoxylin for single staining according to previously described protocols (30) (31) (32) . Images (100×, 400×) were acquired with an Olympus CX31 microscope and Olympus FV1000 confocal microscope.
cell sorting
Positive selection was adopted for obtaining CD8 + T cells from PBMCs using the MiniMACS system (Miltenyi Biotech, Bergisch-Gladbach, Germany) according to the manufacturer's instructions. CD8
+ T cells were then stained with anti-CD8-PECy7 (BD Biosciences, Franklin Lakes, NJ, USA) and anti-CXCR5-Alexa Flour 488 (BD Biosciences, Franklin Lakes, NJ, USA) for 30 min at room temperature and sorted using a FACSAriaII. The purity of the sorted cells was >95% for all sorting experiments.
Killing assay
To investigate the killing capacity of CXCR5 + CD8 + T and CXCR5
cells with Jurkat cells [HIV-infected CD4
+ T cells (33)] integration of the HIV cDNA stimulated by overlapping peptides covering the HIV-1 pol, gag, and env antigens (JPT, Berlin, Germany). The total cells were stimulated by the peptide pools (1 µg/mL, 100 µL per sample) and brefeldin A for 8 h at 37°C in the presence of 5% CO2 before conducting surface and intracellular staining (6) . To evaluate the level of apoptosis, the cells were washed with FACS buffer and stained with CD4-APC (eBioscience, Waltham, MA, USA), 7-AAD-PerCP (BD Biosciences, Franklin Lakes, NJ, USA) and Annexin V-PE (Southern Biotech, Birmingham, AL, USA). Flow cytometric acquisition was performed on a FACSVerse or Caliber.
statistical analysis
All data were analyzed using SPSS version 22. A non-parametric Kruskal-Wallis test was used for multiple comparisons among different groups, and a Mann-Whitney U test was used for the comparison between two groups. A paired Student's t-test was adopted for the analysis with or without PD-L1. The correlations between variables were evaluated by a Spearman rank correlation test. For all tests, P values <0.05 indicated a significant difference (28 
T cells and peripheral CD4
+ T cell counts ( Figure 1C ; r = 0.367; p = 0.003). Furthermore, the increased amount of HIV-specific CXCR5 +
CD8
+ T cells was associated with higher CD4 + T cell counts ( Figures 1D,E left) , with better correlation coefficient and significance probability than that of CXCR5 −
+ T cells (Figure 1E right) . In addition, the absolute counts ( Figure 1F ) of peripheral HIV-specific CXCR5 +
+ T cells were inversely correlated with the viral load. Thus, these data suggest that chronic HIV infection induced CXCR5 +
+ T cells, which are associated with disease progression during chronic HIV infection.
cXcr5
+ cD8 + T cells in ln correlated with cD4 + T cell counts
To visualize CXCR5 + CD8 + T cells in the LN, immunohistochemical staining was performed using antibodies against CXCR5, CD8, and CD20. Double-positive staining of CXCR5 (dark blue) and CD8 (red) was defined as CXCR5 +
CD8
+ T cells, CD20 was used for the identification of germinal center (GC). As shown in Figure 2A , the LNs from HIV-infected patients with low CD4 + T cell counts (<200 cells/μL) exhibited an impaired lymphoid structure, including broken lymphoid follicles, few CD8 + T cells, and enhanced tissue fibrosis. Moreover, few CXCR5 + CD8 + T cells were found (Figure 2A left) . By contrast, in the LNs from HIVinfected patients with CD4
+ T cell counts above 200 cells/μL, the lymphoid structure remained relatively intact, accompanied by normal lymphoid follicles and lymphocyte distribution (Figure 2A 
+ T cells increased with the elevation of peripheral CD4 + T cell counts ( Figure 3D ).
PD-1 Pathway Blockade reduced iFn-γ and TnF-α Production of cXcr5 + cD8 + T cells in response to Tcr stimulation
Considering a PD-1 pathway blockade as an immunological strategy to restore CTL function during chronic HIV infection (14, 17, 21) , we investigated the effect of a PD-1 pathway blockade on both CXCR5
− and CXCR5 + CD8 + T cells in response to short-term TCR stimulation in vitro. After an 8-h stimulation using HIV-1 derived overlapping peptides with or without anti-PD-L1, the levels of IFN-γ, TNF-α, and CD107a were detected as functional markers of HIV-specific CTL responses. In agreement with previous reports (11), the PD-1 blockade significantly restored the production of IFN-γ and TNF-α (Figures 4A,B 
CD8
+ T cells (Figures 4A,B) . Consistent with previous reports (9), a significant fraction of CXCR5 + CD8 + T cells produced granzyme B and perforin and granzyme B was significantly lower in CXCR5 
+ T cells (Figures 4C,D) . To validate the function of PD-1 on CXCR5 +
+ T cells, we purified CXCR5
+ and CXCR5 -CD8 + T cells from the PBMCs. As shown in Figure 5A , the purity of the individual populations was greater than 95%. In response to TCR stimulation, CXCR5 +
+ T cells produced higher levels of IFN-γ, TNF-α, and CD107a than CXCR5 -
+ T cells ( Figure 5B) ; however, the PD-1 blockade exhibited the opposite effect on CXCR5 + and CXCR5
−
CD8
+ T cells regarding the production of IFN-γ, TNF-α, and CD107a ( Figure 5B ). This finding was consistent with the data presented in Figure 4 . In agreement with cytokine production, the killing capacity of the CXCR5 Figure 6B ). In addition, the fluorescence intensity of PD-1 was higher on CXCR5 + CD8 + T cells in the CRs (Figure 6C) . Functionally, the total population of CTLs from the CRs produced more IFN-γ and TNF-α in response to stimulation with HIV-derived overlapping peptides (Figure 6D) . Thus, ART retained the quantity of circulating CXCR5 + CD8 + T cells but failed to restore the function of HIV-specific CXCR5 + CD8 + T cells in the INRs.
DiscUssiOn
In this study, we found that HIV-induced CXCR5 + CD8 + T cells correlated with immune control during chronic HIV infection. Unlike CXCR5 -CD8 + T cells which used PD-1 as an exhaustion marker, CXCR5 + CD8 + T cells exclusively retained high PD-1 expression. In addition, high PD-1 expression was associated with CXCR5 + CD8 + T cells functionality. A PD-1 blockade inhibited rather than enhanced the functionality of CXCR5 
CD8
+ T cells may be regarded as a functional population during chronic HIV infection. CXCR5 + CD8 + T cells are induced during chronic HIV or SIV infections (6, 9) . In this study, the correlation analysis between CXCR5 + CD8 + T cells and disease progression in TPs revealed that CXCR5 + CD8 + T cells, especially HIV-specific CXCR5 Moreover, the distribution of CXCR5 + CD8 + T cells in the LNs of HIV-infected patients was analyzed using immunohistochemistry. Although it has been reported that antiviral CD8 + T cells have a limited capacity to migrate to the GCs of the lymphoid tissue in infected patients (36-38), we found that CXCR5 + T cells in GCs compared to T cell areas. During chronic SIV infection, SIV-specific CXCR5 + CD8 + T cells have been identified within the extrafollicular and intrafollicular regions of the lymphoid tissue (37) . All these results indicate that CXCR5 + CD8 + T cells could enter the GC during HIV infection.
Programmed cell death 1 is considered to be an exhaustion marker expressed on CD8 + T cells during chronic infection or tumor progression (10) (11) (12) (14) (15) (16) (17) ; however, PD-1 expression on CXCR5 +
+ T cells during chronic HIV infection remains poorly defined. In this study, we found that high expression of PD-1 was maintained on CXCR5 + CD8 + T cells and HIV-specific 
+ T cells produced more IFN-γ, TNF-α, and CD107a than CXCR5 −
+ T cells in response to short-term TCR stimulation in vitro. This result is in agreement with other reports (6, 8, 22, 40) . These findings indicate that CXCR5 
+ T cells after PD-1 pathway inhibition. There are some differences between Petrovas's study and this study: differences in patients, tissue, stimulus, and culture conditions. The functional changes of CXCR5 + CD8 + T cells after − , or CXCR5 + CD8 + T cells stimulated for 8 h using HIV-derived overlapping peptides ex vivo (n > 8 for each group). Each dot represents one individual patient. Statistical significance between two groups was determined by a Mann-Whitney non-parametric U test. PD-1 blockade in HIV-infected patients need to be intensive studied in a large number of patients. In addition, in this study, we just detected the effect of blockaded PD-1 for a short time on HIV-specific CXCR5 + CD8 + T cells, it is also an important issue to know the effect of blockaded PD-1for a long time on HIV-specific CXCR5 + CD8 + T cells. In this study, we found that the ability of CXCR5 +
+ T cells to produce perforin and granzyme B was lower than that of CXCR5 −
+ T cells without PD-1 pathway blockade, and this result is consistent with some previous reports (8, 9, 21 
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